SPOTLIGHT: FDA deems Medtronic warning a 'recall'

Oh, by the way, that was a recall. The FDA tells Medtronic that its January warning to doctors--of the increased inflammation risk when its drug infusion systems SynchroMed and IsoMed were used with certain meds--would be classified as a Class I recall. The categorization doesn't change the warning or its recommendations. Report

Launch Readiness

Optimize cross-functional collaboration and engage with key stakeholders for the successful launch of a product

Join the Launch Readiness for Medical Affairs & Communications Teams Summit to learn best practices in taking a structured approach to enhance medical affairs activities surrounding a launch and increase knowledge and communication with thought leaders.